ITCH Trial: Protocol for a Randomized, Double Blind Placebo-controlled Trial

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 154 participants.

Also called NCT04742205

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 154 participants (enrolled count) (from the registry)
Sponsor
Kathmandu Medical College and Teaching Hospital (from the registry)
Registry
  • NCT NCT04742205
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Nepal (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04742205. Randomized; triple masking; primary purpose treatment. Start 2021-02-08 (actual); primary completion 2023-12-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ITCH Trial: Protocol for a Randomized, Double Blind Placebo-controlled Trial
Condition
Cerebral Hemorrhage
Intervention (Drug)
Tranexamic Acid 500 MG
Lead sponsor
Kathmandu Medical College and Teaching Hospital (class: other)

Record details

Record id
cardio:ct-nct04742205
Content hash
0e450f037f60288aa8fa62e3e7fc8057659242b52511ceab60448b1467e060a4